NIH-funded research R21 grant

Improving medication adherence in young cancer patients

Official title: A Pilot Feasibility Trial of a Tailored Intervention to Improve Adherence in Adolescents and Young Adults with Cancer

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-10753573 · Data updated 2026-11-12

This study is looking to help teenagers and young adults with cancer stick to their medication by figuring out their unique challenges and providing personalized support to make it easier for them to follow their treatment plans.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startDecember 12, 2022
Project endNovember 30, 2025
Funding year2024
Award (this year)$184,234
NIH project number5R21CA268945-02
Project IDNIH-10753573 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adolescents and young adults aged 15 to 39 who are undergoing treatment for cancer.

Less likely to help

Patients who are not currently receiving cancer treatment or those outside the age range of 15 to 39 may not benefit from this research.

What this research studies

This research aims to enhance medication adherence among adolescents and young adults (AYAs) with cancer by tailoring interventions to address their specific barriers. The study recognizes that up to 60% of AYAs struggle to follow their treatment plans, which can lead to serious health risks. By identifying individual challenges and applying customized behavior change techniques, the research seeks to create a more effective approach to support these patients in sticking to their medication regimens. The pilot trial will assess the feasibility of this tailored intervention in a clinical setting.

Why it matters

Potential benefit: If successful, this research could significantly improve treatment adherence and health outcomes for young cancer patients.

How similar studies have gone: Previous research has shown that tailored interventions can be more effective than standard approaches, indicating potential success for this novel strategy.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Mcgrady, Meghan Eileen — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Mcgrady, Meghan Eileen

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.